ERBB2 and breast cancer: In predicting the SLN status in breast cancer patients, researchers evaluated the CancerMath model to estimate the probability of having positive lymph nodes and found that addition of prognostic factors human epidermal growth factor receptor 2 (HER-2) and Ki67 could help in improving the classification performances (16, 17).